日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

DFT calculation of Ac(3+) and Bi(3+) complexation with hybrid chelator 3p-C-DEPA for targeted alpha therapy

利用DFT计算杂化螯合剂3p-C-DEPA与Ac(3+)和Bi(3+)络合,用于靶向α疗法

Ramdhani, Danni; Watabe, Hiroshi; Ahenkorah, Stephen; Nuwarda, Rina F; Hardianto, Ari; Janitra, Regaputra S

A Cursory Gaze at Solitary Radiopharmaceutical Chelators Incorporating Macrocyclic and Acyclic Moieties

粗略观察含有大环和非环部分的孤立放射性药物螯合剂

Ahenkorah, Stephen; Ramdhani, Danni

Preclinical characterization of 3p-C-DEPA(-NCS) and 3p-C-DEPA(-TFP)-PEG(4) as potential Actinium-225 bifunctional chelators using DOTA(-NCS) and macropa(-NCS) as benchmarks.

以 DOTA(-NCS) 和 macropa(-NCS) 为基准,对 3p-C-DEPA(-NCS) 和 3p-C-DEPA(-TFP)-PEG(4) 作为潜在的锕-225 双功能螯合剂进行临床前表征。

Pougoue Ketchemen Jessica, Ahenkorah Stephen, Nwangele Emmanuel, Malaza Siphelele Siphesihle Pearl, Ooms Maarten, Cardinaels Thomas, Leekens Simon, Cleeren Frederik, Fonge Humphrey

Radiochemical and Biological Evaluation of 3p-C-NETA-ePSMA-16, a Promising PSMA-Targeting Agent for Radiotheranostics.

3p-C-NETA-ePSMA-16 的放射化学和生物学评价,一种有前景的用于放射治疗诊断的 PSMA 靶向剂

Murce Erika, Ahenkorah Stephen, Beekman Savanne, Handula Maryana, Stuurman Debra, de Ridder Corrina, Cleeren Frederik, Seimbille Yann

Bismuth-213 for Targeted Radionuclide Therapy: From Atom to Bedside

用于靶向放射性核素治疗的铋-213:从原子到床边

Ahenkorah, Stephen; Cassells, Irwin; Deroose, Christophe M; Cardinaels, Thomas; Burgoyne, Andrew R; Bormans, Guy; Ooms, Maarten; Cleeren, Frederik

Radiolabeling of Human Serum Albumin With Terbium-161 Using Mild Conditions and Evaluation of in vivo Stability

在温和条件下用铽-161对人血清白蛋白进行放射性标记并评价其体内稳定性

Cassells, Irwin; Ahenkorah, Stephen; Burgoyne, Andrew R; Van de Voorde, Michiel; Deroose, Christophe M; Cardinaels, Thomas; Bormans, Guy; Ooms, Maarten; Cleeren, Frederik